Africure Pharmaceuticals Ltd 2023 Interim Results For The First Quarter

Africure Pharmaceuticals Ltd ( Q12023 Interim Report

By Published On: November 30, 2022TYPE: Interim ReportsYear: 2023Period: Q1Country: MauritiusSector: Pharmaceuticals

Africure Pharmaceuticals Ltd ( listed on the Stock Exchange of Mauritius under the Pharmaceuticals sector has released it’s 2023 interim results for the first quarter.

For more information about Africure Pharmaceuticals Ltd ( reports, abridged reports, interim earnings results and earnings presentations visit the Africure Pharmaceuticals Ltd ( company page on AfricanFinancials.

Africure Pharmaceuticals Ltd 2023 interim results for the first quarter

Company Profile

Africure Pharmaceuticals Ltd is a manufacturer and distributor of high quality essential medication in Africa. It was incorporated on 17 March 2017 and holds a Global Business Licence issued by the Financial Services Commission. The principal activity of the Company is investment holding, trading & procurement of pharmaceutical products. Africure Pharmaceuticals Ltd is listed on the Stock Exchange of Mauritius